Alembic Pharma zooms on getting tentative approval for Empagliflozin, Metformin Hydrochloride Tablets

20 Jul 2020 Evaluate

Alembic Pharmaceuticals is currently trading at Rs. 1022.75, up by 45.85 points or 4.69% from its previous closing of Rs. 976.90 on the BSE.

The scrip opened at Rs. 980.00 and has touched a high and low of Rs. 1038.40 and Rs. 980.00 respectively. So far 35382 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1,038.40 on 20-Jul-2020 and a 52 week low of Rs. 436.10 on 23-Mar-2020.

Last one week high and low of the scrip stood at Rs. 1038.40 and Rs. 937.00 respectively. The current market cap of the company is Rs. 19460.50 crore.

The promoters holding in the company stood at 72.97%, while Institutions and Non-Institutions held 14.40% and 12.63% respectively.

Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Empagliflozin and Metformin Hydrochloride Tablets, 5 mg/500 mg, 5 mg/1000 mg, 12.5 mg/500 mg, and 12.5 mg/1000 mg.

Empagliflozin and Metformin Hydrochloride Tablets, 5 mg/500 mg, 5 mg/1000 mg, 12.5 mg/500 mg, and 12.5 mg/1000 mg have an estimated market size of $172 million for twelve months ending March 2020. The company now has a total of 126 ANDA approvals (111 final approvals and 15 tentative approvals) from USFDA.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

877.15 -7.95 (-0.90%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×